Cardiovascular Aging: The Next Frontier in Cardiovascular Prevention

Preventive Cardiology: Companion to Braunwald's Heart Disease Expert Consult - Online and Print

Volumn , Issue , 2011, Pages 415-432

  Najjar, Samer S ^a   Lakatta, Edward G ^b   Gerstenblith, Gary ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85134248545     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1366-4.00025-1     Document Type: Chapter

References (147)

1. The World Health Report 1997-conquering, suffering, enriching humanity, Geneva, 1997, World Health Organization.
2. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837.
3. Fleg JL, Gerstenblith G, Zonderman AB, et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 1990, 81:428.
4. Maggioni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med 1993, 329:1442.
5. Najjar SS, Scuteri A, Lakatta EG Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension 2005, 46:454.
6. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 Update. Circulation 2010, 121:e46.
7. Lakatta EG Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490.
8. Lakatta EG, Levy D Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139.
9. Lakatta EG Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993, 73:413.
10. Farasat SM, Morrell CH, Scuteri A, et al. Pulse pressure is inversely related to aortic root diameter implications for the pathogenesis of systolic hypertension. Hypertension 2008, 51:196.
11. Virmani R, Avolio AP, Mergner WJ, et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol 1991, 139:1119.
12. Adams MR, Nakagomi A, Keech A, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995, 92:2127.
13. Asai K, Kudej RK, Shen YT, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 2000, 20:1493.
14. Lakatta EG, Wang M, Najjar SS Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. Med Clin North Am 2009, 93:583.
15. Najjar SS IMT as a risk marker: the plot thickens. J Am Soc Echocardiogr 2009, 22:505.
16. Scuteri A, Chen CH, Yin FC, et al. Functional correlates of central arterial geometric phenotypes. Hypertension 2001, 38:1471.
17. Scuteri A, Manolio TA, Marino EK, et al. Prevalence of specific variant carotid geometric patterns and incidence of cardiovascular events in older persons. The Cardiovascular Health Study (CHS E-131). J Am Coll Cardiol 2004, 43:187.
18. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588.
19. Wildman RP, Farhat GN, Patel AS, et al. Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension 2005, 45:187.
20. Wilkinson IB, Franklin SS, Cockcroft JR Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 2004, 44:1126.
21. Tarasov KV, Sanna S, Scuteri A, et al. COL4A1 is associated with arterial stiffness by genome-wide association scan. Circ Cardiovasc Genet 2009, 2:151.
22. Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001, 104:1464.
23. Bakris GL, Bank AJ, Kass DA, et al. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 2004, 17:23S.
24. Avolio AP, Van Bortel LM, Boutouyrie P, et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009, 54:375.
25. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1213.
26. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003, 361:1149.
27. Roman MJ, Devereux RB, Kizer JR, et al. High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol 2009, 54:1730.
28. Wang KL, Cheng HM, Sung SH, et al. Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study. Hypertension 2010, 55:799.
29. Franklin SS, Gustin Wt, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96:308.
30. Chantler PD, Lakatta EG, Najjar SS Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol 2008, 105:1342.
31. Redfield MM, Jacobsen SJ, Borlaug BA, et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005, 112:2254.
32. Najjar SS, Schulman SP, Gerstenblith G, et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol 2004, 44:611.
33. Nussbacher A, Gerstenblith G, O'Connor F, et al. Hemodynamic effects of unloading the old heart. Am J Physiol 1999, 277:H1863.
34. Gerhard M, Roddy MA, Creager SJ, Creager MA Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996, 27:849.
35. Taddei S, Virdis A, Mattei P, et al. Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996, 94:1298.
36. Minamino T, Miyauchi H, Yoshida T, et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541.
37. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108:457.
38. Conboy IM, Conboy MJ, Wagers AJ, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760.
39. Thum T, Hoeber S, Froese S, et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007, 100:434.
40. Leinwand LA Sex is a potent modifier of the cardiovascular system. J Clin Invest 2003, 112:302.
41. Konhilas JP, Leinwand LA The effects of biological sex and diet on the development of heart failure. Circulation 2007, 116:2747.
42. Fermin DR, Barac A, Lee S, et al. Sex and age dimorphism of myocardial gene expression in nonischemic human heart failure. Circ Cardiovasc Genet 2008, 1:117.
43. Brodde OE, Konschak U, Becker K, et al. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J Clin Invest 1998, 101:471.
44. Lakatta EG Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999, 47:613.
45. Dai DF, Santana LF, Vermulst M, et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009, 119:2789.
46. Younes A, Boluyt MO, O'Neill L, et al. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am J Physiol 1995, 38:H1003.
47. Grant JE, Bradshaw AD, Schwacke JH, et al. Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus. J Proteome Res 2009, 8:4252.
48. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type I receptor promotes longevity in mice. J Clin Invest 2009, 119:524.
49. Finkel T, Holbrook NJ Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239.
50. Lakatta EG, Levy D Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003, 107:346.
51. Bedard K, Krause KH The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245.
52. Grieve DJ, Byrne JA, Siva A, et al. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 2006, 47:817.
53. Johar S, Cave AC, Narayanapanicker A, et al. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 2006, 20:1546.
54. Looi YH, Grieve DJ, Siva A, et al. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 2008, 51:319.
55. Dworakowski R, Walker S, Momin A, et al. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. J Am Coll Cardiol 2008, 51:1349.
56. Maack C, Kartes T, Kilter H, et al. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 2003, 108:1567.
57. Csiszar A, Labinskyy N, Smith K, et al. Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am J Pathol 2007, 170:388.
58. Janczewski AM, Spurgeon HA, Lakatta EG Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca 2+ regulation. J Mol Cell Cardiol 2002, 34:641.
59. Pepe S, Xiao RP, Hohl C, et al. "Cross-talk" between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 1997, 95:2122.
60. Grandy SA, Howlett SE Cardiac excitation-contraction coupling is altered in myocytes from aged male mice but not in cells from aged female mice. Am J Physiol 2006, 291:H2362.
61. Lakatta EG Functional implications of spontaneous sarcoplasmic reticulum Ca 2+ release in the heart. Cardiovasc Res 1992, 26:193.
62. Lakatta EG, Sollott SJ, Pepe S The old heart: operating on the edge. Ageing vulnerability: causes and interventions 2001, 172-201. Wiley, New York, Novartis Foundation Symposium 235. G. Bock, J. Goode (Eds.).
63. Tate CA, Taffet GE, Hudson EK, et al. Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats. Am J Physiol 1990, 258:H431.
64. Hansford RG, Zorov D Role of mitochondrial calcium transport in the control of substrate oxidation. Mol Cell Biochem 1998, 184:359.
65. Pepe S, Tsuchiya N, Lakatta EG, Hansford RG PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca 2+ activation of PDH. Am J Physiol 1999, 276:H149.
66. Sohal R, Arnold L, Sohal B Age-related changes in antioxidant enzymes and prooxidant generation in tissues of the rat with special reference to parameters in two insect species. Free Radic Biol Med 1990, 10:495.
67. Tani M, Suganuma Y, Hasegawa H, et al. Decrease in ischemic tolerance with aging in isolated perfused Fischer 344 rat hearts: relation to increases in intracellular Na + after ischemia. J Mol Cell Cardiol 1997, 29:3081.
68. Chou TC, Yen MH, Li CY, Ding YA Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 1998, 31:643.
69. Korzick DH, Holiman DA, Boluyt MO, et al. Diminished alpha 1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am J Physiol Heart Circ Physiol 2001, 281:H581.
70. Zorov DB, Filburn CR, Klotz LO, et al. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000, 192:1001.
71. Farsetti A, Crasselli A, Bacchetti S, et al. The telomerase tale in vascular aging: regulation by estrogen and nitric oxide signaling. J Appl Physiol 2009, 106:333.
72. Blasig I, Grune T, Schonheit K, et al. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol 1995, 269:H14.
73. Lucas D, Szweda L Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of ketoglutarate dehydrogenase. Proc Natl Acad Sci U S A 1999, 96:6689.
74. Paradies G, Ruggiero FM, Petrosillo G, et al. Effect of aging and acetyl- l-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett 1994, 350:213.
75. Halstrup A, Kerr P, Javador S, Woodfield K Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury in the heart. Biochim Biophys Acta 1998, 1366:79.
76. Yin FC, Spurgeon HA, Weisfeldt ML, Lakatta EG Mechanical properties of myocardium from hypertrophied rat hearts. A comparison between hypertrophy induced by senescence and by aortic banding. Circ Res 1980, 46:292.
77. Shida M, Isoyama S Effects of age on c-fos and c-myc gene expression in response to hemodynamic stress in isolated, perfused rat hearts. J Mol Cell Cardiol 1993, 25:1025.
78. Boluyt MO, Lakatta EG Cardiovascular aging in health. Heart metabolism in failure 1998, 257-303. JAI Press, Greenwich, Conn. R.A. Altschuld, R.A. Haworth (Eds.).
79. Shunkert H, Weinberg E, Bruckschlegel G, et al. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest 1995, 96:2768.
80. Kadokami T, McTiernan CF, Kubota T, et al. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest 2000, 106:589.
81. Janczewski AM, Kadokami T, Lemster B, et al. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF. Am J Physiol 2003, 284:H960.
82. Chimenti C, Kajstura J, Torella D, et al. Senescence and death of primitive cells and myocytes leads to premature cardiac aging and heart failure. Circ Res 2003, 93:604.
83. Gonzalez A, Rota M, Nurzynska D, et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res 2008, 102:597.
84. Seals DR, DeSouza CA, Donato AJ, Tanaka H Habitual exercise and arterial aging. J Appl Physiol 2008, 105:1323.
85. Leri A, Malhotra A, Liew CC, et al. Telomerase activity in rat cardiac myocytes is age and gender dependent. J Mol Cell Cardiol 2000, 32:385.
86. Rota M, Hosoda T, De Angelis A, et al. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res 2007, 101:387.
87. Anversa P, Rota M, Urbanek K, et al. Myocardial aging-a stem cell problem. Basic Res Cardiol 2005, 100:482.
88. Kajstura J, Urbanek K, Rota M, et al. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol 2008, 45:505.
89. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004, 94:514.
90. Li Q, Wu S, SY Li, et al. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am J Physiol 2007, 292:H1398.
91. Blair SN, Kohl HW, Paffenbarger RS, et al. Physical fitness and all-cause mortality: a prospective study of men and women. JAMA 1989, 262:2395.
92. Avolio AP, Fa-Quan D, Wei-Qiang L, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985, 71:202.
93. Tanaka H, Dinenno FA, Monahan KD, et al. Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000, 102:1270.
94. Tanaka H, DeSouza CA, Seals DR Absence of age-related increases in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 1998, 18:127.
95. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993, 88:1456.
96. Shibata S, Hastings JL, Prasad A, et al. "Dynamic" Starling mechanism: effects of ageing and physical fitness on ventricular-arterial coupling. J Physiol 2008, 586:1951.
97. Shi X, Schaller FA, Tierney N, et al. Physically active lifestyle enhances vagal-cardiac function but not central autonomic neural interaction in elderly humans. Exp Biol Med 2008, 233:209.
98. Spina RJ, Meyer TE, Peterson LR Absence of left ventricular and arterial adaptations to exercise in octogenarians. J Appl Physiol 2004, 97:1654.
99. Braith RW, Stewart KJ Resistance exercise training. Its role in the prevention of cardiovascular disease. Circulation 2006, 113:2642.
100. Miyachi M, Kawano H, Sugawara J, et al. Unfavorable effects of resistance training on central arterial compliance. A randomized intervention study. Circulation 2004, 110:2858.
101. Cortez-Cooper MY, DeVan AE, Anton MM, et al. Effects of high intensity resistance training on arterial stiffness and wave reflection in women. Am J Hypertens 2005, 18:930.
102. Rakobowchuk M, McGowan CL, de Groot PC, et al. Effect of whole body resistance training on arterial compliance in young men. Exp Physiol 2005, 90:645.
103. Brades RP, Fleming I, Busse R Endothelial aging. Cardiovasc Res 2005, 66:286.
104. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995, 91:1981.
105. Black MA, Green DJ, Cable NT Exercise prevents age-related decline in nitric-oxide mediated vasodilator function in cutaneous microvessels. J Physiol 2008, 586:3511.
106. DeSouza CA, Shapiro LF, Clevenger CM, et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000, 102:1351.
107. Laughlin MH, Newcomer SC, Bender SB Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype. J Appl Physiol 2008, 104:588.
108. Green DJ, Maiorana A, O'Driscoll G, Taylor R Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 2004, 561:1.
109. Van Guilder GP, Westby CM, Greiner JJ, et al. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 2007, 50:403.
110. Smith DT, Hoetzer GL, Greiner JJ, et al. Effects of aging and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J Physiol 2003, 546:289.
111. Brosse AL, Sheets ES, Lett HS, Blumenthal JA Exercise and the treatment of clinical depression in adults. Recent findings and future directions. Sports Med 2002, 32:741.
112. Thijsssen DHJ, Vos JB, Verseyden C, et al. Hematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 2006, 5:495.
113. Nelson ME, Rajeski WJ, Blair SN, et al. Physical activity and public health in older adults. Recommendations from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116:1094.
114. Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994, 89:52.
115. Miller VM, Duckles SP Vascular actions of estrogen: functional implications. Pharmacol Rev 2008, 60:210.
116. Moriarity K, Kim KH, Bender JR Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 2006, 147:5557.
117. Stirone C, Duckles SP, Krause DN, Procaccio V Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 2005, 68:959.
118. Strehlow K, Werner N, Berweiler J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003, 107:3059.
119. Anderson GL, Limacher M, Assad AR, et al. Women's Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701.
120. Hayashi T, Maeda S, Iemitsu M, et al. Sex differences in the relationship between estrogen receptor alpha gene polymorphisms and arterial stiffness in older humans. Am J Hypertens 2007, 20:650.
121. Traish AM, Saad F, Feeley RJ, Guays A The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009, 30:477.
122. Vitale C, Mendelsohn ME, Rosano GMC Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009, 6:532.
123. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7.
124. Wenger NK, Lewis SJ, Herrington DM, et al. Treating to New Targets Study Steering Committee and Investigators: Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med 2007, 147:1.
125. Zeng L, Xu H, Chew TL, et al. HMG-CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation. FASEB J 2005, 19:1845.
126. Spyridopoulos I, Haendeler J, Urbich C, et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004, 110:3136.
127. Satoh M, Minami Y, Takahashi Y, et al. Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clin Sci (London) 2009, 116:827.
128. Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903.
129. Gueyffier F, Bulpitt C, Boissel JP, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. Lancet 1999, 353:793.
130. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255.
131. Verdecchia P, Staessen JjA, Angeli F, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomized trial. Lancet 2009, 374:525.
132. Mallareddy M, Parikh CR, Peixoto AJ Effect of angiotensin-converting enzyme inhibitors on arterial stiffness in hypertension: systematic review and meta-analysis. J Clin Hypertens 2006, 8:398.
133. Ceconi C, Fox KM, Remme WJ, et al. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study. Cardiovasc Res 2007, 73:237.
134. Schriffrin EL, Park JB, Intengan HD Correction of arterial structure and endothelial function in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000, 101:1653.
135. Mahmud A, Feely J Reduction in arterial stiffness with angiotensin II antagonist is comparable with an additive to ACE inhibition. Am J Hypertens 2002, 15:321.
136. Yusuf S, Teo KK, Pogue J Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008, 358:1547. ONTARGET Investigators.
137. Jansen PM, Danser AH, Imholz BP, van den Meiracker AH Aldosterone-receptor antagonism in hypertension. J Hypertens 2009, 27:680.
138. Brown NJ Aldosterone and vascular inflammation. Hypertension 2008, 51:161.
139. Strauch B, Petrak O, Wichterie D, et al. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 2006, 19:909.
140. Mahmud A, Feely J Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens 2005, 18:50.
141. Savoia C, Touz RM, Amin F, Schiffrin EL Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008, 51:432.
142. Centers for Disease Control and Prevention (CDC) Cigarette smoking among adults and trends in smoking cessation-United States, 2008. MMWR Morb Mortal Wkly Rep 2009, 58:1227.
143. Pope CA, Burnett RT, Krewski D, et al. Cardiovascular mortality and exposure to airborne fine particular matter and cigarette smoke. Circulation 2009, 120:941.
144. Barnoya J, Glantz SA Cardiovascular effects of secondhand smoke. Circulation 2005, 111:2684.
145. Heiss C, Amabile N, Lee AC, et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function. J Am Coll Cardiol 2008, 51:1760.
146. Kondo T, Hayashi M, Takeshita K, et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004, 24:1442.
147. Juster HR, Loomis BR, Hinman TM, et al. Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health 2007, 97:2035.